Axsome Thera
(AXSM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,753 | 42,625 | 13,969 | 15,221 | 20,351 |
| TOTAL | $54,568 | $43,759 | $15,215 | $15,944 | $21,539 |
| Non-Current Assets | |||||
| PPE Net | 41 | 40 | 52 | 64 | 69 |
| Other Non-Current Assets | 169 | 102 | 112 | 117 | 117 |
| TOTAL | $210 | $142 | $164 | $181 | $186 |
| Total Assets | $54,778 | $43,901 | $15,379 | $16,126 | $21,725 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,155 | 536 | N/A | N/A | 3,280 |
| Accounts payable and accrued liabilities | 6,137 | 3,434 | 3,687 | 4,167 | 3,175 |
| Accrued Expenses | 4,778 | 3,740 | 3,843 | 3,388 | 2,954 |
| Other current liabilities | N/A | N/A | N/A | 102 | 117 |
| TOTAL | $13,070 | $7,710 | $10,822 | $10,943 | $9,526 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,425 | 18,818 | 3,619 | 4,440 | 5,191 |
| TOTAL | $17,425 | $18,818 | $3,619 | $4,440 | $5,191 |
| Total Liabilities | $30,495 | $26,527 | $14,441 | $15,383 | $14,717 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,419 | 33,305 | 33,280 | 29,813 | 26,253 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -131,953 | -118,191 | -107,550 | -97,953 | -89,671 |
| TOTAL | $24,283 | $17,374 | $938 | $743 | $7,009 |
| Total Liabilities And Equity | $54,778 | $43,901 | $15,379 | $16,126 | $21,725 |